Pain and numbing in RF microneedling

2026-09-29

RF microneedling usually feels like brief heat, pressure and pinpricks rather than one continuous sensation. Topical anaesthetic can reduce surface pain but not every deeper heat sensation. Tell the practitioner immediately if pain becomes sharp, focal or escalating. Persistent severe pain, blisters or marked swelling after treatment need prompt clinical assessment.

What RF microneedling feels like at each stage

Facial radiofrequency microneedling combines needle entry with heat delivered through needles at a selected depth. The feeling is therefore not identical to ordinary microneedling, nor to heat delivered across the skin surface. Most people notice several distinct sensations: the application and removal of numbing cream, pressure from the handpiece, short pinpricks as the needles enter, then a quick internal heat or sting as energy is released.

Before treatment, the skin is usually cleansed and assessed. Cleansing can sting if the barrier is already irritated, for example after recent exfoliating products, shaving cuts or active dermatitis. During treatment, the forehead, upper lip, bony cheek area and jawline are often more sensitive than the fleshy central cheeks. Sensitivity also differs between individuals, between treatment days and across menstrual, inflammatory or medication-related changes in the skin.

The intensity should be discussed in real time. A tolerable sequence of brief, anticipated pulses is different from uncontrolled pain. The practitioner should be able to pause, reassess the area and explain whether needle depth, energy, pulse pattern, overlap or the treatment area is responsible for the sensation. Do not assume that severe pain proves a more effective treatment. Treatment settings are a dose decision, not a test of endurance.

This page concerns facial treatment. It does not set treatment settings or replace an individual assessment. For the wider sequence after a session, see the site’s recovery timeline. For preparation, consent and the steps after leaving the appointment, see RF microneedling assessment, treatment plan and aftercare.

Topical anaesthetic: what it can and cannot numb

A topical local anaesthetic is applied to intact skin before many RF microneedling procedures to reduce discomfort from needle entry. It generally reduces sensation in the outer layers of skin. It does not necessarily remove pressure, the sound of the device, or every deeper warmth produced when radiofrequency energy is delivered. A person can therefore be well numbed at the surface yet still notice a short hot sensation with deeper passes.

The timing is product-specific. The Summary of Product Characteristics for lidocaine and prilocaine cream describes a 60-minute application time before procedures on intact skin, but that does not make 60 minutes a universal instruction for every formulation, area or patient. The practitioner should follow the authorised product information, use an amount appropriate to the area, record what was used and remove the product fully before treatment. Occlusion may be part of a product’s instructions, but it is not something to improvise at home.

Tell the practitioner before numbing cream is applied if you have reacted to local anaesthetics, adhesives or creams; have a history of methaemoglobinaemia; have significant liver disease; are pregnant or breastfeeding; or take prescription medicines. These details may change whether a topical agent is suitable or whether treatment should be deferred. Broken, inflamed or infected skin also needs individual assessment because absorption and irritation can differ.

Do not add extra cream, use a leftover product, cover a larger area than directed or combine products in an effort to make treatment painless. Excess topical anaesthetic can create avoidable safety risks. Numbness that remains for a while after cream removal can be expected; systemic symptoms such as dizziness, ringing in the ears, a metallic taste, confusion or palpitations require urgent medical advice.

Decision rule: when to speak up during the procedure

The useful distinction is not whether any discomfort occurs, but whether it remains brief, localised and responsive to adjustment. Use the rule below before consenting to another pass. It is designed for discussion with the treating practitioner, not for diagnosing a complication from home.

A clear consent conversation should establish a signal for pausing, especially if the face is partly numb and speech is awkward. A hand raise is simple. Pain should never be reframed as something a patient has to tolerate because a session has started. The site’s questions to ask page can help structure this conversation before the appointment.

What the practitioner can change if it is too much

There are several variables in RF microneedling, and discomfort can be a reason to reassess rather than simply continue. The practitioner may stop and inspect the skin, allow time for cooling, avoid a particularly sensitive area, reduce energy, alter pulse delivery, reduce needle depth, reduce overlap or decide not to perform further passes. Which changes are technically appropriate depends on the device, treatment goal, skin area and the observed tissue response.

Depth is relevant because facial anatomy is uneven. Skin thickness, proximity to bone, previous scarring and the location of nerves all vary across the face. A setting that is acceptable on one zone should not be treated as automatically suitable for another. More intensity is not automatically more useful, particularly where the skin has already become significantly red, swollen or painful during the session.

Cooling may improve comfort after a pass, but it is not a substitute for stopping treatment when pain is concerning. Similarly, topical anaesthetic is one element of a plan, not permission to ignore feedback. If numbing has not achieved the expected effect, the options can include changing the plan, rearranging after reassessment or deciding not to treat that day.

A practitioner should also consider factors that may have made the day different: recent sun exposure, active acne lesions, a rash, recent waxing or shaving injury, a new active skincare product, illness, or medicines that affect sensation or healing. The correct response may be postponement. That is particularly important where the skin barrier is compromised.

For a fuller account of pre-treatment screening and aftercare instructions, consult RF microneedling assessment, treatment plan and aftercare. That page complements, rather than replaces, direct instructions from the clinician responsible for treatment.

The first hours afterwards: expected discomfort and care

Once numbness fades, the face may feel warm, tight, tender or sunburned. Redness and mild swelling can make the skin feel more sensitive than it looks. Pinpoint marks may be visible, depending on the treatment parameters and individual response. These effects are commonly most noticeable soon after the procedure and should be managed according to the clinician’s written aftercare instructions.

A cool compress may be advised, but avoid placing ice directly onto recently treated skin. Rubbing, picking at pinpoint crusting, vigorous exercise, heat exposure and unapproved active products can increase irritation during the early recovery period. Use only the cleansing, moisturising and sun-protection steps you have been given. This page does not prescribe post-procedure topicals, as suitability depends on the treatment and the state of the skin.

Discomfort should generally settle rather than gather force. It is useful to make a note of the time treatment ended, when numbness wore off, and whether pain is improving, static or escalating. Photographs in consistent light can also help a clinician assess a change if advice is needed. Do not rely on photographs alone where there is severe pain or rapidly changing swelling.

Normal recovery varies with settings, treatment area and individual skin response. The site’s recovery timeline sets out the broader pattern readers may encounter after RF microneedling. It should not be used to dismiss symptoms that feel materially different from the recovery advice given at the appointment.

When pain or altered sensation is a warning sign

Seek prompt medical advice if pain is severe, worsening, disproportionate to the visible redness, or not controlled by the aftercare plan supplied to you. Contact the treating clinician promptly for new blisters, skin peeling beyond minor pinpoint crusting, increasing local swelling, pus, spreading redness, fever, or a patch that becomes unusually pale, grey, purple or dark. These signs need assessment because burns, infection and pigmentary change require different management.

Altered sensation also matters. Persistent numbness, tingling, weakness or severe touch sensitivity should be reported, particularly if it is one-sided or develops after the immediate effect of topical anaesthetic should have passed. Difficulty breathing, facial swelling involving the lips or tongue, widespread hives, fainting or confusion requires emergency help rather than waiting for a routine response.

People with more pigment-prone skin may be especially concerned by new darkening or lightening after inflammation. A colour change can emerge later than the first day, so document it and ask for review rather than applying stronger products in response. Early irritation is not proof that permanent pigment change will occur, but it is a reason for careful advice.

The site’s risks and complications page covers the wider distinction between expected recovery and complications. It cannot determine what is happening in an individual case. If you are worried, use the contact route provided by the treating service and seek medical assessment where symptoms are urgent or escalating.

Limits of this guide

This is a UK-facing reference guide to sensation and numbing in facial RF microneedling, including treatment performed with the Morpheus8 device. It is not a treatment protocol, a substitute for the device instructions for use, or individual medical advice. It does not compare providers, assess complaints, recommend a clinic or set a suitable treatment course.

It also does not cover body RF treatments, surgical lifting, injectable anaesthesia, sedation, or which products should be applied after treatment. Those questions involve different procedures, risks or clinical responsibilities. People under the care of a dermatologist, surgeon, pain specialist or other clinician should follow the advice of that team where it differs from general information.

People with active infection, open wounds, an unexplained rash, a history of serious reactions to local anaesthetics, altered facial sensation, or a medical condition affecting healing need individual assessment before proceeding. A test patch may be considered where there is a history suggesting contact sensitivity to a proposed topical product, but it cannot guarantee that a full-area application or the procedure itself will be tolerated.

The practical rule is straightforward: anticipated brief discomfort can be discussed and adjusted; severe, focal, escalating or unusual pain should stop the process and trigger assessment. Bring questions about numbing, pauses, settings and aftercare to the consultation rather than trying to solve them on the day alone.